prostate institute

prostate institute

Painful, Slow & Stinging Urination?
Watch This Video Before You Buy Anything

Vaccine against cancer of the prostate allows patients to live longer

Yesterday, the initial findings of a study on cancer patients Prostate released. It seems that for the first time in the history of a vaccine against cancer is to delay the progression of the disease and patients live longer hours in May.

This vaccine is desperately needed for asymptomatic advanced cancer of the prostate is known to be resistant hormone therapy is used in early prostate cancers detected and no further treatment is effective against it.

Eric J. Small quantities of the University of California, San Francisco, said this trial is very important because it opens the door to other treatments for prostate cancer.

L. Gulley National Cancer Institute was very excited with the discovery and said that the vaccine is important not only for those who suffer from the disease but also for the field. This vaccine confirms what we all deny that vaccines that can really work.

This vaccine is unlike the others which are intended to prevent disease. This is done to treat the prostate cancer advances to enhance the immune response cancer cells.

The vaccine was made from a protein genetically modified dendritic cells and always the patient's bloodstream. Three shots of vaccine were made during a month. The immune system will react and activate T cells in the system immune to find and destroy cancer cells.

Eric J. Petit, along with 19 other institutions of the United States conducted the study was funded by the Dendreon Corporation (the developer of the vaccine), based in Seattle, Washington. Small included in the study of 127 patients of asymptomatic metastatic hormone prostate cancer (HRPC). The 82 received vaccine and 45 placebo.

For those treated with the vaccine, the average survival was 25.9 months. For those who received placebo treatment, overall survival was 21.4 months.
The conclusions were that this group of 115 patients a progressive disease at the time of data analysis and all patients were followed for survival for 3 years.

The vaccine was well tolerated by patients and side effects were mild fever and chills. Five subjects reported having mild urinary problems. This is good news because chemotherapy gives many side effects intolerable.

Most patients can continue treatment based on surgery, radiotherapy and hormone therapy, but asymptomatic metastatic HRPC is known to be resistant to hormonal therapy, and annually more than 30,000 men die, because no other treatment is effective against the disease, so treatment is an urgent need.

For more information about prostate cancer treatment and cancer Prostate please review this http://www.prostate-cancer-center.com site Web

About the Author

For more information about prostate cancer treatment and about prostate cancer please review this web site http://www.prostate-cancer-center.com

Prostate cancer is diagnosed more cancer. But support why there is no equality of prostate cancer?

The breast cancer rate of prostate cancer research $ 548mill to $ 306 million by the NCI (National Cancer Institute). Although there are more cancer diagnoses prostate cancer in new cases per 230,110 to 215,990 (www.cancer.org/downloads/MED/Page4.pdf). No events to raise money for cancer breast as fundraising pink ribbon is great, but where is the ribbon for prostate cancer? It telethons for breast cancer, 10k races, breast cancer, collected Flight Aircraft for breast cancer. There is equal support for prostate cancer Although the prostate is diagnosed more than breast cancer. Why? Why women are more concerned than men? Does anyone find this disturbing?

I must place this week, everyone. Because cancer breast is more deadly than cancer of the prostate. Men die from prostate cancer is not the same. They are greater including and especially without costly treatment. The exception of a type that affects younger men that we receive research $ $. As it should. The five survival rate is 99% and for Breast cancer is now 79%. For all these efforts of fundraising – the women did. Men can do the same thing, nobody stopping you. Salto.

Dr. Robert Takamiya – Seattle prostate institute – Brachythrapy – Low risk prostate cancer

Filed under: Prostate

Like this post? Subscribe to my RSS feed and get loads more!